Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype

Winterhoff, Boris J (PI)

Obstetrics, Gynecology and Women's Health - Oncology

Project: Research project

Project Details

Description

Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype

Status	Active
Effective start/end date	3/6/19 → 3/30/24

Funding

UNIVERSITY OF CALIFORNIA, LOS ANGEL

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.